The global cerebral oximetry monitoring market size was valued at USD 217.20 Million in 2024, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2025-2034 to achieve a value of USD 435.32 Million by 2034 .
Cerebral oximeters consist of a monitoring device that is paired with oximeter probes, which are affixed to the patient's scalp with adhesive pads. These probes are generally placed over the frontal lobe region of the scalp. They incorporate fibre optic light sources and light detectors that emit infrared light through either stimulated emission of radiation or light-emitting diodes. The resulting light can penetrate the skull and reach the cerebral tissue below.
The Centers for Disease Control and Prevention (CDC) reports that in the United States alone, nearly 697,000 people have coronary artery disease (CAD) due to lifestyle factors such as smoking, alcohol consumption, and physical inactivity. This rise in CAD cases is expected to increase the demand for cerebral oximetry monitoring devices for safe surgeries. The medical sector is continuously developing and adopting these devices, leading to further market growth. Technological advancements are also expected to boost the cerebral oximetry monitoring device market demand.
Additionally, the increased awareness of combining cerebral oximeters with other technologies is a significant factor driving market growth. Cerebral oximetry monitoring has also been increasingly used in extremely preterm infants to guide treatments for conditions such as low systematic blood flow, low cerebral blood flow, and even risk of ischemia. Such fields can potentially increase the demand for cerebral oximetry monitoring further in the market.
Geographically, North America is leading the global market and is expected to keep leading in the coming years as well. The presence of some of the major key players offering new innovative products and techniques in the region is also a major factor driving the cerebral oximetry monitoring market demand. Cerebral oximetry monitoring is performed to monitor cerebral desaturation in cardiac surgery. The increasing research activities for developing novel cerebral oximeter devices are directly expected to drive the market growth.
This product will be delivered within 3-5 business days.
Cerebral Oximetry Monitoring: Introduction
Cerebral oximeters are non-invasive and continuous monitoring devices that are used to monitor adequate cerebral oxygenation. They utilize similar physical principles to pulse oximeters. Cerebral oximeters are used to measure tissue oxygen saturation, reflecting haemoglobin saturation in arterial, venous, and capillary blood. Cerebral oximetry measures regional tissue saturation in an area of the frontal cortex of nearly 1 cm3. RSO2 values are affected by the physiologic variables that determine brain oxygen supply and demand.Cerebral oximeters consist of a monitoring device that is paired with oximeter probes, which are affixed to the patient's scalp with adhesive pads. These probes are generally placed over the frontal lobe region of the scalp. They incorporate fibre optic light sources and light detectors that emit infrared light through either stimulated emission of radiation or light-emitting diodes. The resulting light can penetrate the skull and reach the cerebral tissue below.
Global Cerebral Oximetry Monitoring Market Analysis
The market for cerebral oximetry monitoring has been experiencing significant growth and is expected to continue growing in the forecast period as well. The thriving ageing population and an increase in diseases like cardiovascular and neurological disorders is significantly contributing to the cerebral oximetry monitoring device market share.The Centers for Disease Control and Prevention (CDC) reports that in the United States alone, nearly 697,000 people have coronary artery disease (CAD) due to lifestyle factors such as smoking, alcohol consumption, and physical inactivity. This rise in CAD cases is expected to increase the demand for cerebral oximetry monitoring devices for safe surgeries. The medical sector is continuously developing and adopting these devices, leading to further market growth. Technological advancements are also expected to boost the cerebral oximetry monitoring device market demand.
Additionally, the increased awareness of combining cerebral oximeters with other technologies is a significant factor driving market growth. Cerebral oximetry monitoring has also been increasingly used in extremely preterm infants to guide treatments for conditions such as low systematic blood flow, low cerebral blood flow, and even risk of ischemia. Such fields can potentially increase the demand for cerebral oximetry monitoring further in the market.
Global Cerebral Oximetry Monitoring Market Segmentations
Cerebral Oximetry Monitoring Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Age
- Adult
- Pediatric
Market Breakup by Application
- Cardiac Surgery
- Vascular Surgery
- Others
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cerebral Oximetry Monitoring Market Overview
The increasing geriatric population and increasing prevalence of chronic diseases are major factors driving the market growth. The increasing awareness about non-invasive monitoring procedures, which is further contributing to the increased demand for such procedures as cerebral oximetry monitoring, is propelling the market growth. The cerebral oximetry monitoring market growth is also driven by continuous technological advancement. Another factor responsible for the growth of the market is the expanded utilization of cerebral oximetry monitoring in several medical specialties such as neurology, cardiovascular surgeries, and anesthesia, among others.Geographically, North America is leading the global market and is expected to keep leading in the coming years as well. The presence of some of the major key players offering new innovative products and techniques in the region is also a major factor driving the cerebral oximetry monitoring market demand. Cerebral oximetry monitoring is performed to monitor cerebral desaturation in cardiac surgery. The increasing research activities for developing novel cerebral oximeter devices are directly expected to drive the market growth.
Global Cerebral Oximetry Monitoring Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Medtronic
- Masimo
- Edwards Lifesciences Corporation
- Nonin
- ISS, Inc.
- GE Healthcare
- Hamamatsu Photonics K.K.
- Terumo Cardiovascular Systems Corporation
- Mespere LifeSciences
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Cerebral Oximetry Monitoring Market Overview
4 Global Cerebral Oximetry Monitoring Market Landscape
5 Global Cerebral Oximetry Monitoring Market Dynamics
6 Global Cerebral Oximetry Monitoring Market Segmentation
7 North America Cerebral Oximetry Monitoring Market
8 Europe Cerebral Oximetry Monitoring Market
9 Asia Pacific Cerebral Oximetry Monitoring Market
10 Latin America Cerebral Oximetry Monitoring Market
11 Middle East and Africa Cerebral Oximetry Monitoring Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Cerebral Oximetry Monitoring Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Medtronic
- Masimo
- Edwards Lifesciences Corporation
- Nonin
- Financial Portfolio
- ISS, Inc.
- GE Healthcare
- Hamamatsu Photonics K.K.
- Terumo Cardiovascular Systems Corporation
- Mespere LifeSciences